Congress has passed a series of reforms intended to lower prescription drug prices, though some industry analysts say the impact may be less than expected.
The reforms affect the operation of pharmacy benefit managers, companies that negotiate prescription drug prices for health insurers, and employer-sponsored health plans.
Independent pharmacists and some members of Congress had long sought these reforms but were unable to get them through both houses of Congress.
The changes were finally passed as part of the Consolidated Appropriations Act of 2026, which was signed by President Donald Trump on Feb. 3.
“This was a win for the patient. This was a win for all Americans. It was a win for health care,” Rep. Buddy Carter (R-Ga.), a pharmacist and advocate for reform, told reporters on Feb. 4….
Congress Reforms Prescription Drug Supply Change: What to Know
